{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:19:32Z","timestamp":1787973572399,"version":"build-2784847793"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jbspin.2019.12.004","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T11:40:15Z","timestamp":1579261215000},"page":"413-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cardiovascular risk in psoriatic arthritis, a narrative review"],"prefix":"10.1016","volume":"87","author":[{"given":"Frank","family":"Verhoeven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4682-4489","authenticated-orcid":false,"given":"Cl\u00e9ment","family":"Prati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Demougeot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4687-5780","authenticated-orcid":false,"given":"Daniel","family":"Wendling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2019.12.004_bib0005","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","article-title":"The pathogenesis of psoriatic arthritis","volume":"391","author":"Veale","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.40726","article-title":"Special Article: 2018 American College of Rheumatology\/National Psoriasis Foundation Guideline for the treatment of psoriatic arthritis","volume":"71","author":"Singh","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2015-208337","article-title":"European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update","volume":"75","author":"Gossec","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"7","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jbspin.2017.11.001","article-title":"Treatment strategies for psoriatic arthritis","volume":"85","author":"Schemoul","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0030","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","article-title":"Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis","volume":"3","author":"Peters","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0035","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0040","first-page":"S62","article-title":"Mortality in psoriatic arthritis","volume":"26","author":"Gladman","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0045","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N","article-title":"Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death","volume":"41","author":"Gladman","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0050","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/art.1780401021","article-title":"Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I.\u00a0Causes and risk of death","volume":"40","author":"Wong","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0055","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/rheumatology\/kew502","article-title":"Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis","volume":"56","author":"Ogdie","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0060","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/annrheumdis-2016-209562","article-title":"Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap","volume":"76","author":"Lacaille","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0065","first-page":"731","article-title":"Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project","volume":"37","author":"Mart\u00edn-Mart\u00ednez","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/rheumatology\/key241","article-title":"Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register","volume":"58","author":"Fagerli","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13075-017-1315-z","article-title":"Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study","volume":"19","author":"Bengtsson","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/acr.22926","article-title":"Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta-analysis of observational studies","volume":"69","author":"Polachek","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13075-017-1358-1","article-title":"Cardiovascular disease risk profiles in inflammatory joint disease entities","volume":"19","author":"Wibetoe","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0090","doi-asserted-by":"crossref","first-page":"e000588","DOI":"10.1136\/rmdopen-2017-000588","article-title":"Real-world burden of comorbidities in US patients with psoriatic arthritis","volume":"3","author":"Shah","year":"2017","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0095","doi-asserted-by":"crossref","first-page":"e000630","DOI":"10.1136\/rmdopen-2017-000630","article-title":"Change in cardiovascular risk factors in patients who develop psoriatic arthritis: longitudinal data from the Nord-Tr\u00f8ndelag Health Study (HUNT)","volume":"4","author":"Gulati","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0100","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/s10067-019-04528-y","article-title":"Cardiac and cardiovascular morbidities in patients with psoriatic arthritis: a population-based case control study","volume":"38","author":"Kibari","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0105","first-page":"122","article-title":"Higher incidence rates of comorbidities in patients with psoriatic arthritis compared with the general population using U.S.\u00a0Administrative Claims Data","volume":"2","author":"Kaine","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.semarthrit.2018.03.005","article-title":"Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis","volume":"48","author":"Cooksey","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0115","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/acr.23171","article-title":"Incidence and prevalence of cardiovascular risk factors among patients with rheumatoid arthritis, psoriasis, or psoriatic arthritis","volume":"69","author":"Radner","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00296-016-3614-0","article-title":"Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study","volume":"37","author":"Nissen","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/acr.23094","article-title":"Incidence and management of cardiovascular risk factors in psoriatic arthritis and rheumatoid arthritis: a population-based study","volume":"69","author":"Jafri","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s41927-018-0032-9","article-title":"Cardiovascular risk management in rheumatoid and psoriatic arthritis: online survey results from a national cohort study","volume":"2","author":"Sinnathurai","year":"2018","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0135","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/13696998.2018.1431921","article-title":"Comorbidity and economic burden among moderate-to-severe psoriasis and\/or psoriatic arthritis patients in the US Department of Defense population","volume":"21","author":"Lee","year":"2018","journal-title":"J Med Econ"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12895-017-0063-8","article-title":"Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR)","volume":"17","author":"Schneeweiss","year":"2017","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0145","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10067-018-4042-1","article-title":"Prevalence and type II diabetes-associated factors in psoriatic arthritis","volume":"37","author":"Queiro","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0150","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3899\/jrheum.170379","article-title":"Gaps in diagnosis and treatment of cardiovascular risk factors in patients with psoriatic disease: an international multicenter study","volume":"45","author":"Eder","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0155","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/art.40389","article-title":"Higher coronary plaque burden in psoriatic arthritis is independent of metabolic syndrome and associated with underlying disease severity","volume":"70","author":"Szentpetery","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0160","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3899\/jrheum.180670","article-title":"Burden and disease characteristics of patients with psoriatic arthritis: a population-based cross-sectional study","volume":"46","author":"Tekin","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0165","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/key286","article-title":"Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study","volume":"58","author":"Charlton","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0170","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/acr.23609","article-title":"Subsequent cardiovascular events among patients with rheumatoid arthritis, psoriatic arthritis, or psoriasis: patterns of disease-modifying antirheumatic drug treatment","volume":"71","author":"Sparks","year":"2019","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0175","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0180","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3899\/jrheum.161274","article-title":"Endocrine comorbidities in patients with psoriatic arthritis: a population-based case-controlled study","volume":"44","author":"Haddad","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0185","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2147\/TCRM.S130666","article-title":"Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis\/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients","volume":"13","author":"Chen","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/annrheumdis-2017-211625","article-title":"The smoking paradox in the development of psoriatic arthritis among psoriasis patients \u2013 A population-based study","volume":"77","author":"Uyen-Sa","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/1744666X.2019.1543591","article-title":"The relationship between smoking, psoriasis and psoriatic arthritis","volume":"15","author":"Pezzolo","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0200","doi-asserted-by":"crossref","first-page":"7689208","DOI":"10.1155\/2019\/7689208","article-title":"Concordance between the different cardiovascular risk scores in people with rheumatoid arthritis and psoriasis arthritis","volume":"2019","author":"Gonzalez-Martin","year":"2019","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0205","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/RHU.0000000000000721","article-title":"Increased prevalence of metabolic syndrome and adipocytokine levels in a psoriatic arthritis cohort","volume":"24","author":"Feld","year":"2018","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1346-8138.14706","article-title":"Metabolic syndrome and psoriatic arthritis among patients with psoriasis vulgaris: quality of life and prevalence","volume":"46","author":"Souza","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0215","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jamasurg.2016.4610","article-title":"Incidence and prognosis of psoriasis and psoriatic arthritis in patients undergoing bariatric surgery","volume":"152","author":"Egeberg","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0220","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/oby.21955","article-title":"Bariatric surgery and the incidence of psoriasis and psoriatic arthritis in the Swedish obese subjects study","volume":"25","author":"Maglio","year":"2017","journal-title":"Obesity"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0225","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5114\/aoms.2018.74021","article-title":"Serum lipid metabolism in psoriasis and psoriatic arthritis \u2013 an update","volume":"15","author":"Pietrzak","year":"2019","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0230","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/art.40499","article-title":"Correlation of high-density lipoprotein-associated paraoxonase 1 activity with systemic inflammation, disease activity, and cardiovascular risk factors in psoriatic disease","volume":"70","author":"Husni","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071890","article-title":"Systemic inflammatory response and atherosclerosis: the paradigm of chronic inflammatory rheumatic diseases","author":"Arida","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0240","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jbspin.2014.01.014","article-title":"Endothelial dysfunction in joint disease","volume":"81","author":"Prati","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0245","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0036-1584918","article-title":"Atherosclerosis in psoriatic arthritis: a multiparametric analysis using imaging technique and laboratory markers of inflammation and vascular function","volume":"25","author":"Garg","year":"2016","journal-title":"Int J Angiol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0250","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jamacardio.2017.1213","article-title":"Association between skin and aortic vascular inflammation in patients with psoriasis: a case-cohort study using positron emission tomography\/computed tomography","volume":"2","author":"Dey","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0255","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jamacardio.2018.2769","article-title":"Association between aortic vascular inflammation and coronary artery plaque characteristics in psoriasis","volume":"3","author":"Joshi","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0260","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jid.2017.02.977","article-title":"TNF-a antagonist and vascular inflammation in patients with psoriasis vulgaris: a randomized placebo-controlled study","volume":"137","author":"Robert Bissonnette","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0265","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0270","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13075-018-1669-x","article-title":"Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study","volume":"20","author":"Lee","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0275","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.atherosclerosis.2017.09.033","article-title":"Diclofenac but not celecoxib improves endothelial function in rheumatoid arthritis: a study in adjuvant-induced arthritis","volume":"266","author":"Verhoeven","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0280","first-page":"CD012722","article-title":"Methotrexate for psoriatic arthritis","volume":"1","author":"Wilsdon","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0285","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13075-017-1439-1","article-title":"Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis","volume":"19","author":"Deyab","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0290","first-page":"81","article-title":"Methotrexate did not improve endothelial function in rheumatoid arthritis: a study in rats with adjuvant-induced arthritis","volume":"37","author":"Bordy","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0295","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/138161282004140213123852","article-title":"Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review","volume":"20","author":"Brezinski","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jbspin.2019.12.004_bib0300","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/art.40366","article-title":"Association of tumor necrosis factor inhibitor treatment with reduced indices of subclinical atherosclerosis in patients with psoriatic disease","volume":"70","author":"Eder","year":"2018","journal-title":"Arthritis Rheumatol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X2030004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X2030004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:27:14Z","timestamp":1761150434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X2030004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1297319X2030004X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.12.004","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular risk in psoriatic arthritis, a narrative review","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}